Variant type and patient sex affect molnupiravir efficacy, study finds

SARS-CoV-2 variants of concern and the biological sex of patients affect the efficacy of molnupiravir, the first orally available drug approved for outpatient use against COVID-19, according to a new study.

from Top Health News -- ScienceDaily https://ift.tt/Xgv8w9O